Table 3.
Descriptive and Inferential statistics for the CBT and TAU Conditions.
| Measure | Baseline | Post-treatment | Follow-up | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||
| CBT M (SD) |
TAU M (SD) |
CBT M (SD) |
TAU M (SD) |
tx | dx | CBT M (SD) |
ty | dy | tz | dz | |
| PARS | 15.81 (1.64) | 15.67 (2.50) | 10.94 (3.91) | 13.93 (3.56) | 2.21* | 0.79 | 9.78 (3.38) | −0.38 | −0.13 | 6.15** | 2.05 |
| ADIS CSRa | 5.50 (1.03) | 5.73 (0.80) | 3.69 (1.35) | 5.33 (0.90) | 3.84** | 1.30 | 2.47 (2.31) | 1.08 | 0.39 | 4.01** | 1.44 |
| CGI-Severity | 3.69 (0.60) | 3.93 (0.80) | 2.88 (0.72) | 3.67 (0.82) | 2.68* | 0.94 | 2.67 (0.50) | 0.00 | 0.00 | 5.55** | 1.85 |
| SRS | |||||||||||
| Awareness | 12.50 (3.60) | 14.47 (3.14) | 10.00 (3.29) | 13.27 (3.06) | 2.31* | 0.75 | 8.11 (2.09) | 1.81 | 0.60 | 3.90** | 1.30 |
| Cognition | 19.06 (5.87) | 20.67 (5.64) | 14.69 (5.40) | 19.80 (5.35) | 2.77** | 0.76 | 10.89 (4.43) | 4.66** | 1.55 | 8.40** | 2.80 |
| Communication | 38.06 (8.57) | 38.13 (9.44) | 27.13 (8.52) | 36.67 (9.20) | 3.75** | 1.13 | 19.78 (5.04) | 3.57** | 1.19 | 6.49** | 2.16 |
| Motivation | 18.19 (5.90) | 18.33 (5.59) | 15.13 (6.62) | 17.53 (6.60) | 1.28 | 0.35 | 10.11 (3.37) | 3.38** | 1.13 | 3.63** | 1.21 |
| Mannerisms | 18.13 (5.98) | 21.33 (6.07) | 14.00 (8.22) | 20.13 (5.99) | 1.76 | 0.52 | 7.78 (3.93) | 4.18** | 1.39 | 8.37** | 2.79 |
| Total | 105.94 (22.64) | 112.93 (24.77) | 80.94 (26.83) | 107.40 (24.53) | 2.80** | 0.84 | 56.67 (12.95) | 5.68** | 1.89 | 9.36** | 3.12 |
| RCADS | 27.94 (15.42) | 27.05 (20.86) | 23.86 (15.24) | 21.88 (17.19) | −0.30 | −0.09 | 23.12 (16.44) | −0.83 | −0.30 | 1.54 | 0.52 |
| MASC-P | 62.33 (19.99) | 64.37 (11.56) | 56.94 (17.52) | 58.62 (17.56) | 0.10 | 0.03 | 45.89 (19.69) | 1.12 | 0.44 | 1.23 | 0.44 |
| CIS-P | 23.52 (7.51) | 25.67 (7.45) | 17.24 (9.75) | 24.96 (8.91) | 2.58* | 0.59 | 18.00 (7.31) | −0.97 | −0.32 | 2.46* | 0.86 |
| CBCL | |||||||||||
| Internalizing | 28.12 (11.27) | 23.55 (8.16) | 18.79 (8.73) | 20.07 (6.89) | 1.94 | 0.48 | 17.33 (10.78) | −0.71 | −0.24 | 3.11* | 1.11 |
| Externalizing | 15.63 (10.03) | 15.70 (11.09) | 10.79 (8.48) | 15.92 (10.88) | 3.28** | 0.63 | 8.98 (6.77) | −0.98 | −0.40 | 1.48 | 0.56 |
Note.
**
p<.01;
*
p<.05
a
Clinical severity rating associated with principal diagnosis
x
Post-treatment analyses evaluated the effect of treatment condition while accounting for baseline group differences
y
Analyses compare 1-month follow-up to post-treatment status for treatment responders who returned for a follow-up assessment
z
Analyses compare 1-month follow-up to baseline status for treatment responders who returned for a follow-up assessment.